<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00529672</url>
  </required_header>
  <id_info>
    <org_study_id>2005-325</org_study_id>
    <nct_id>NCT00529672</nct_id>
  </id_info>
  <brief_title>Surgery or Noninvasive Therapy for Varicose Veins</brief_title>
  <acronym>Magna</acronym>
  <official_title>Randomized Single Center Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerotherapy With Foam and Endovenous Laser Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For more than 100 years, surgery has been the standard of care of varicose veins of the legs.
      The down side of surgery is that it requires anesthesia, leaves scars, and has a relatively
      high recurrence rate in the long term (up to 40%). In the last decade, several new techniques
      have become available but they have not yet been compared to surgery. This trail will
      evaluate the effectiveness, patients` perspective and cost effectiveness of surgery and
      non-invasive techniques such as ultrasound guided sclerotherapy with foam and endovenous
      laser therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria:

        -  Ultrasound confirmed GSV insufficiency (reflux time &gt;0.5 second and vein diameter â‰¥0.5
           cm)

        -  non-treated GSV varicosis

        -  CEAP -classification &gt; C2 and As2

        -  &gt;18 years old

        -  Informed consent.

      Exclusion criteria:

        -  Acute venous thrombosis / phlebitis

        -  Absence of deep venous system

        -  Vascular syndromes

        -  Post-thrombotic syndrome of occlusive type

        -  Contra-indications for surgery

        -  use of anticoagulants

      Primary outcomes:

      1. anatomical success using US (absence of GSV or flow) (at 3 months, 1 and 5 year)

      Secondary outcomes:

        1. treatment induced adverse events and complications (after 3 months)

        2. patient reported outcomes (HRQOL and treatment satisfaction)(after 3 months)

        3. cost effectiveness analyses (after 1 and 5 years)

      Included patients: total of 240 (80 per arm)

      Study start: May 2007 (recruitment ongoing) Study completion: May 2011

      Follow up after 3 months, 1, 2, 3, 4 and 5 years

      Location: department of dermatology, Erasmus MC, Rotterdam, The Netherlands

      Principle investigators: M. Kockaert, T. Nijsten &amp; M. Neumann

      Publications:

      Rasmussen LH, Bjoern L, Lawaetz M, Blemings A, Lawaetz B, Eklof B. Randomized trial comparing
      endovenous laser ablation of the great saphenous vein with high ligation and stripping in
      patients with varicose veins: short-term results. J Vasc Surg. 2007 Aug;46(2):308-15. Epub
      2007 Jun 27.

      Sharif MA, Lau LL, Lee B, Hannon RJ, Soong CV. Role of endovenous laser treatment in the
      management of chronic venous insufficiency. Ann Vasc Surg. 2007 Sep;21(5):551-5.

      Mundy L, Merlin TL, Fitridge RA, Hiller JE. Systematic review of endovenous laser treatment
      for varicose veins. Br J Surg. 2005 Oct;92(10):1189-94.

      Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C.Systematic review of foam sclerotherapy
      for varicose veins. Br J Surg. 2007 Aug;94(8):925-36.

      Subramonia S, Lees TA.The treatment of varicose veins.Ann R Coll Surg Engl. 2007
      Mar;89(2):96-100.

      Bohler K. Varicose veins: disfigurement or disease? Herz. 2007 Feb;32(1):18-25.

      Bamigboye AA, Smyth R. Interventions for varicose veins and leg oedema in pregnancy. Cochrane
      Database Syst Rev. 2007 Jan 24;(1):CD001066.

      van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. New endovenous therapies of
      truncal varicosities are more effective than surgical stripping and sclerotherapy:
      meta-analysis and meta-regression. Lancet, Submitted
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anatomical success rate (absence or obliteration of GSV on US examination)</measure>
    <time_frame>3 months, 1 and 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment related adverse events and complications</measure>
    <time_frame>3 months, 1 and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient reported outcomes (HRQOL and treatment satisfaction)</measure>
    <time_frame>3 months, 1 and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost effectiveness analysis</measure>
    <time_frame>3 months, 1 and 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Varicose Vein</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgery: crossectomy plus short stripping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound guided sclerotherapy with foam (3% polidocanol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endovenous laser therapy (940 nm, about 70 J/cm)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>crossectomy and short stripping</intervention_name>
    <description>under spinal or complete anaesthesia</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound guided sclerotherapy with foam</intervention_name>
    <description>1 part 3% polidocanol mixed with 3 parts of air. Between 3cc - 12 cc per varicose vein&gt;</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endovenous laser therapy</intervention_name>
    <description>940 nm Diode laser. About 70 J/cm will be administered. Disposables from Angiocare (registered) will be used.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary insufficient GSV confirmed by US: reflux&gt;0.5 sec and diameter&gt;0.5cm.

          -  non-treated insufficient GSV

          -  &gt;18 years

          -  informed consent

        Exclusion Criteria:

          -  acute thrombosis or phlebitis

          -  absence of deep venous system

          -  vascular syndromes

          -  use of anticoagulants

          -  contraindications surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martino Neumann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Kockaert, MD</last_name>
    <phone>31 10 4634580</phone>
    <email>M.KOCKAERT@ERASMUSMC.NL</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tamar Nijsten, MD, PhD</last_name>
    <phone>31 10 4631019</phone>
    <email>t.nijsten@erasmusmc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasmus MC dermatology</name>
      <address>
        <city>Rotterdam</city>
        <zip>3000 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kockaert, MD</last_name>
      <phone>31 10 4634580</phone>
      <email>m.kockaert@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Tamar Nijsten, MD, PhD</last_name>
      <phone>31 10 4631019</phone>
      <email>t.nijsten@ersmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Prof. sambeek, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2007</study_first_submitted>
  <study_first_submitted_qc>September 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2007</study_first_posted>
  <last_update_submitted>November 15, 2010</last_update_submitted>
  <last_update_submitted_qc>November 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. TEC Nijsten</name_title>
    <organization>Erasmus MC</organization>
  </responsible_party>
  <keyword>endovenous laser therapy</keyword>
  <keyword>sclerotherapy</keyword>
  <keyword>crossectomy and stripping</keyword>
  <keyword>surgery</keyword>
  <keyword>treatment</keyword>
  <keyword>varicose veins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

